Bruker Corporation's next confirmed earnings release is scheduled for November 4, 2026.
| Earnings Date | 11/4/2026 |
As of June 30, 2026, Bruker Corporation has 152.35M shares outstanding.
| Shares Outstanding | 152.35M |
As of June 30, 2026, Bruker Corporation maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 74.92, indicating elevated leverage, while an interest coverage ratio of 3.24 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.85 |
| Quick Ratio | 0.83 |
| Debt / Equity | 74.92 |
| Debt / EBITDA | 9.15 |
| Interest Coverage | 3.24 |
Over the twelve months ended June 30, 2026, Bruker Corporation posted a negative return on equity (ROE) of -5.11, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.15, reflecting losses generated across the asset base. The company generates approximately 274,412.66 in revenue per employee across its workforce of 11,162.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.60 indicates how many times Bruker Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -5.11 |
| Return on Assets (ROA) | -1.15 |
| Revenue Per Employee | 274,412.66 |
| Employee Count | 11,162.75 |
| Inventory Turnover | 1.60 |
Over the twelve months ended June 30, 2026, Bruker Corporation recorded 35.36M in income tax expense. The company reported a pretax loss of -19.61M and -62.32M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 35.36M |
Over the twelve months ended June 30, 2026, Bruker Corporation generated 3.06B in revenue and converted that into -62.32M in net income, yielding earnings per share of -0.37. EBITDA reached 174.62M, while operating income came in at 232.83M.
| Revenue | 3.06B |
| Gross Profit | 1.42B |
| Operating Income | 232.83M |
| Pretax Income | -19.61M |
| Net Income | -62.32M |
| EBITDA | 174.62M |
| EBIT | -26.78M |
| Earnings Per Share (EPS) | -0.37 |
As of June 30, 2026, Bruker Corporation holds 194.75M in cash and equivalents against 1.60B in total debt, resulting in a net debt position of 1.44B. Total book value stands at 2.08B, with working capital of 893.07M providing operational flexibility.
| Cash & Cash Equivalents | 194.75M |
| Total Debt | 1.60B |
| Net Debt | 1.44B |
| Equity (Book Value) | 2.08B |
| Book Value Per Share | 13.68 |
| Working Capital | 893.07M |
Bruker Corporation produced 166.66M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -84.47M in capital expenditures, free cash flow totaled 82.19M - equivalent to 0.54 per share.
| Operating Cash Flow | 166.66M |
| Capital Expenditures | -84.47M |
| Free Cash Flow | 82.19M |
| FCF Per Share | 0.54 |
Over the twelve months ended June 30, 2026, Bruker Corporation posted a gross margin of 46.42, reflecting its pricing power and cost economics. The operating margin of 7.60 and net profit margin of -2.03 provide insight into operational efficiency.
| Gross Margin | 46.42 |
| Operating Margin | 7.60 |
| Pretax Margin | -0.64 |
| Profit Margin | -2.03 |
| EBITDA Margin | 5.70 |
Over the twelve months ended June 30, 2026, Bruker Corporation paid dividends of 0.31 per share. The dividend payout ratio of -20.32 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.
| Dividend Per Share | 0.31 |
| Payout Ratio | -20.32 |